TKTL1
Transketolase-like protein 1
Also known as: TKR, TKT2, TKTL1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51854
- Gene
- TKTL1
- Ensembl
- ENSG00000007350
- Chromosome
- X
- Canonical length
- 596 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a transketolase that acts as a homodimer and catalyzes the conversion of sedoheptulose 7-phosphate and D-glyceraldehyde 3-phosphate to D-ribose 5-phosphate and D-xylulose 5-phosphate. This reaction links the pentose phosphate pathway with the glycolytic pathway. Variations in this gene may be the cause of Wernicke-Korsakoff syndrome. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
Canonical amino-acid sequenceUniProt
596 residues, UniProt reviewed canonical sequence.
>P51854|TKTL1
1 MADAEARAEF PEEARPDRGT LQVLQDMASR LRIHSIRATC STSSGHPTSC SSSSEIMSVL
61 FFYIMRYKQS DPENPDNDRF VLAKRLSFVD VATGWLGQGL GVACGMAYTG KYFDRASYRV
121 FCLMSDGESS EGSVWEAMAF ASYYSLDNLV AIFDVNRLGH SGALPAEHCI NIYQRRCEAF
181 GWNTYVVDGR DVEALCQVFW QASQVKHKPT AVVAKTFKGR GTPSIEDAES WHAKPMPRER
241 ADAIIKLIES QIQTSRNLDP QPPIEDSPEV NITDVRMTSP PDYRVGDKIA TRKACGLALA
301 KLGYANNRVV VLDGDTRYST FSEIFNKEYP ERFIECFMAE QNMVSVALGC ASRGRTIAFA
361 STFAAFLTRA FDHIRIGGLA ESNINIIGSH CGVSVGDDGA SQMALEDIAM FRTIPKCTIF
421 YPTDAVSTEH AVALAANAKG MCFIRTTRPE TMVIYTPQER FEIGQAKVLR HCVSDKVTVI
481 GAGITVYEAL AAADELSKQD IFIRVIDLFT IKPLDVATIV SSAKATEGRI ITVEDHYPQG
541 GIGEAVCAAV SMDPDIQVHS LAVSGVPQSG KSEELLDMYG ISARHIIVAV KCMLLNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TKTL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.21
- Highest tissue expression
- 119 nTPM
Expression across tissuesHPA
Tissue
- testis: 119 nTPM
- heart muscle: 3.6 nTPM
- retina: 2 nTPM
- ovary: 1.8 nTPM
- bone marrow: 0.9 nTPM
- lung: 0.9 nTPM
Single-cell type
- differentiating spermatogonia: 678 nCPM
- oocytes: 438 nCPM
- early primary spermatocytes: 371 nCPM
- undifferentiated spermatogonia: 203 nCPM
- early spermatids: 38 nCPM
- epididymal basal cells: 35 nCPM
Immune cell
- eosinophil: 61 nTPM
- gdT-cell: 25 nTPM
- NK-cell: 7.8 nTPM
- naive CD4 T-cell: 6.1 nTPM
- total PBMC: 5.8 nTPM
- naive CD8 T-cell: 5.4 nTPM
Brain region
- cerebral cortex: 8.7 nTPM
- medulla oblongata: 3.1 nTPM
- choroid plexus: 0.8 nTPM
- pons: 0.8 nTPM
- thalamus: 0.8 nTPM
- spinal cord: 0.6 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.14
- gnomAD pLI
- 1
- gnomAD missense Z
- -0.85
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transketolase, N-terminal
- Transketolase-like, pyrimidine-binding domain
- Transketolase C-terminal/Pyruvate-ferredoxin oxidoreductase domain II
- Transketolase binding site
- Thiamin diphosphate-binding fold
- Transketolase, C-terminal domain
- Transketolase-like
- Transketolase, thiamine diphosphate binding domain
- Transketolase, pyrimidine binding domain
- Transketolase, C-terminal domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TKTL1 as an antibody target. Whether an autoantibody or antibody against TKTL1 could matter depends on whether native TKTL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TKTL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TKTL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...